Trial of Deferiprone in Parkinson’s DiseaseDavid Devos, Christoph Scherfler, Werner Poewe et al.|New England Journal of Medicine|2022Cited by 226
Mitochondrial alterations triggered by repeated exposure to fine (PM2.5-0.18) and quasi-ultrafine (PM0.18) fractions of ambient particulate matterJules Sotty, Guillaume Garçon|Environment International|2020Cited by 62
Toxicological appraisal of the chemical fractions of ambient fine (PM2.5-0.3) and quasi-ultrafine (PM0.3) particles in human bronchial epithelial BEAS-2B cellsGhidaa Badran, Guillaume Garçon|Environmental Pollution|2020Cited by 36